U.S. Trial of Lilly Antibody Therapy to End; No Safety Issue
An Eli Lilly & Co. logo is seen on a box of medication. (Photographer: Daniel Acker/Bloomberg)

U.S. Trial of Lilly Antibody Therapy to End; No Safety Issue

(Bloomberg) -- A paused clinical trial of an Eli Lilly & Co. experimental antibody therapy won’t resume after federal researchers concluded the drug likely wouldn’t help hospitalized Covid-19 patie...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.